Objectives
Our rationale for introducing TXA-soaked NasoPore® to the A&E epistaxis management pathway was to achieve the following aims. Firstly, to reduce local epistaxis admissions, and secondly, to achieve this in a manner which is evidence-based and maintains patient safety.
Methods